Cadingilan, Ambig A.

HRN: 29-02-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/20/2026
05/27/2026
IV
500MG
Q8
HERNIA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: